Dipyridamole-induced STEMI: case report and review of the literature

Authors

  • Hussam Al Hennawi
  • Sunita Lakhani Department of Internal Medicine, Jefferson Abington Hospital, Abington, PA.
  • Shayan Iqbal Khan Department of Internal Medicine, Jefferson Abington Hospital, Abington, PA.
  • Sarin Atam Department of Internal Medicine, Jefferson Abington Hospital, Abington, PA.
  • Usama Sadiq Department of Cardiology, Thomas Jefferson University Hospitals, Philadelphia, PA.
  • Joseph A Rigotti Department of Internal Medicine, Jefferson Abington Hospital, Abington, PA.
  • Abhinav Nair Department of Cardiology, Jefferson Abington Hospital, Abington, PA.

DOI:

https://doi.org/10.21542/gcsp.2023.23

Abstract

Dipyridamole nuclear myocardial perfusion imaging is a safe and useful modality to assess for myocardial ischemia. It is the modality of choice for cardiac risk stratification in patients unable to exercise. Intravenous dipyridamole causes coronary vasodilation and may yield heterogeneity of coronary blood flow in significant coronary artery disease. Ischemic electrocardiographic changes following pharmacologic stress testing are less likely compared to exercise stress tests. Ischemia more likely presents in the form of ST depression, with ST-elevation being exceedingly rare. We present a case of a 73-year-old patient who developed ST-elevation myocardial infarction following pharmacologic stress testing.

Downloads

Published

2023-06-27

Issue

Vol. 2023 No. 3 (2023)

Section

Images in cardiology

License

Copyright (c) 2023 Hussam Al Hennawi, Sunita Lakhani, Shayan Iqbal Khan, Sarin Atam, Usama Sadiq, Joseph A Rigotti, Abhinav Nair

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

This is an open access article distributed under the terms of the Creative Commons Attribution license CC BY 4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.